Transforming growth factor β and its role in heart disease

Nag, 1980, Study of non-muscle cells of the adult mammalian heart: a fine structural analysis and distribution, Cytobios, 28, 41

Pinto, 2016, Revisiting cardiac cellular composition, Circ Res, 118, 400, 10.1161/CIRCRESAHA.115.307778

Souders, 2009, Cardiac fibroblast: the renaissance cell, Circ Res, 105, 1164, 10.1161/CIRCRESAHA.109.209809

Moore-Morris, 2016, Origins of cardiac fibroblasts, J Mol Cell Cardiol, 91, 1, 10.1016/j.yjmcc.2015.12.031

Hinz, 2007, The myofibroblast: one function, multiple origins, Am J Pathol, 170, 1807, 10.2353/ajpath.2007.070112

Leask, 2010, Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation, Circ Res, 106, 1675, 10.1161/CIRCRESAHA.110.217737

Leask, 2008, Targeting the TGFbeta, endothelin-1 and CCN2 axis to combat fibrosis in scleroderma, Cell Signal, 20, 1409, 10.1016/j.cellsig.2008.01.006

Euler, 2015, Good and bad sides of TGFβ-signaling in myocardial infarction, Front Physiol, 6, 66, 10.3389/fphys.2015.00066

Kane, 1991, Direct evidence for spatial and temporal regulation of transforming growth factor beta 1 expression during cutaneous wound healing, J Cell Physiol, 148, 157, 10.1002/jcp.1041480119

Massagué, 1998, TGF-beta signal transduction, Annu Rev Biochem, 67, 753, 10.1146/annurev.biochem.67.1.753

Edgley, 2012, Targeting fibrosis for the treatment of heart failure: a role for transforming growth factor-β, Cardiovasc Ther, 30, e30, 10.1111/j.1755-5922.2010.00228.x

Schneiders, 2005, SMAD proteins are involved in apoptosis induction in ventricular cardiomyocytes, Cardiovasc Res, 67, 87, 10.1016/j.cardiores.2005.02.021

Huntgeburth, 2011, Transforming growth factor β1 oppositely regulates the hypertrophic and contractile response to β-adrenergic stimulation in the heart, PLoS One, 6, e26628, 10.1371/journal.pone.0026628

Vilahur, 2011, Molecular and cellular mechanisms involved in cardiac remodeling after acute myocardial infarction, J Mol Cell Cardiol, 50, 522, 10.1016/j.yjmcc.2010.12.021

Talasaz, 2013, N-Acetylcysteine effects on transforming growth factor-β and tumor necrosis factor-α serum levels as pro-fibrotic and inflammatory biomarkers in patients following ST-segment elevation myocardial infarction, Drugs R D, 13, 199, 10.1007/s40268-013-0025-5

Shinde, 2014, Fibroblasts in myocardial infarction: a role in inflammation and repair, J Mol Cell Cardiol, 70, 74, 10.1016/j.yjmcc.2013.11.015

Cordeiro, 2003, Novel antisense oligonucleotides targeting TGF-beta inhibit in vivo scarring and improve surgical outcome, Gene Ther, 10, 59, 10.1038/sj.gt.3301865

Yamauchi, 2010, Tumor necrosis factor-alpha enhances both epithelial-mesenchymal transition and cell contraction induced in A549 human alveolar epithelial cells by transforming growth factor-beta1, Exp Lung Res, 36, 12, 10.3109/01902140903042589

Maleszewska, 2013, IL-1β and TGFβ2 synergistically induce endothelial to mesenchymal transition in an NFκB-dependent manner, Immunobiology, 218, 443, 10.1016/j.imbio.2012.05.026

Zeisberg, 2007, Endothelial-to-mesenchymal transition contributes to cardiac fibrosis, Nat Med, 13, 952, 10.1038/nm1613

Wrana, 1994, Mechanism of activation of the TGF-beta receptor, Nature, 370, 341, 10.1038/370341a0

Zhang, 1996, Receptor-associated Mad homologues synergize as effectors of the TGF-beta response, Nature, 383, 168, 10.1038/383168a0

Wharton, 2009, TGFbeta family signaling: novel insights in development and disease, Development, 136, 3691, 10.1242/dev.040584

Cunnington, 2009, c-Ski, Smurf2, and Arkadia as regulators of TGF-beta signaling: new targets for managing myofibroblast function and cardiac fibrosis, Can J Physiol Pharmacol, 87, 764, 10.1139/Y09-076

Wrana, 2000, Regulation of Smad activity, Cell, 100, 189, 10.1016/S0092-8674(00)81556-1

Whitman, 1997, Signal transduction. Feedback from inhibitory SMADs, Nature, 389, 549, 10.1038/39202

Dobaczewski, 2011, Transforming growth factor (TGF)-β signaling in cardiac remodeling, J Mol Cell Cardiol, 51, 600, 10.1016/j.yjmcc.2010.10.033

Blahna, 2012, Smad-mediated regulation of microRNA biosynthesis, FEBS Lett, 586, 1906, 10.1016/j.febslet.2012.01.041

Flanders, 2002, Mice lacking Smad3 are protected against cutaneous injury induced by ionizing radiation, Am J Pathol, 160, 1057, 10.1016/S0002-9440(10)64926-7

Bujak, 2007, Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling, Circulation, 116, 2127, 10.1161/CIRCULATIONAHA.107.704197

Yang, 2003, Hierarchical model of gene regulation by transforming growth factor beta, Proc Natl Acad Sci USA, 100, 10269, 10.1073/pnas.1834070100

Verrecchia, 2001, Identification of novel TGF-beta/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach, J Biol Chem, 276, 17058, 10.1074/jbc.M100754200

Santander, 2006, Betaglycan induces TGF-beta signaling in a ligand-independent manner, through activation of the p38 pathway, Cell Signal, 18, 1482, 10.1016/j.cellsig.2005.11.011

Shi-wen, 2009, Requirement of transforming growth factor beta-activated kinase 1 for transforming growth factor beta-induced alpha-smooth muscle actin expression and extracellular matrix contraction in fibroblasts, Arthritis Rheum, 60, 234, 10.1002/art.24223

Wang, 2012, MicroRNA-24 regulates cardiac fibrosis after myocardial infarction, J Cell Mol Med, 16, 2150, 10.1111/j.1582-4934.2012.01523.x

Guo, 2015, Cardiomyocyte-specific role of miR-24 in promoting cell survival, J Cell Mol Med, 19, 103, 10.1111/jcmm.12393

Zhou, 2016, MicroRNA-503 promotes angiotensin II-induced cardiac fibrosis by targeting Apelin-13, J Cell Mol Med, 20, 495, 10.1111/jcmm.12754

Zhao, 2015, MicroRNA-101a inhibits cardiac fibrosis induced by hypoxia via targeting TGFβRI on cardiac fibroblasts, Cell Physiol Biochem, 35, 213, 10.1159/000369689

Zhang, 2014, MicroRNA-92a inhibition attenuates hypoxia/reoxygenation-induced myocardiocyte apoptosis by targeting Smad7, PLoS One, 9, e100298, 10.1371/journal.pone.0100298

Zou, 2016, Autophagy inhibition of hsa-miR-19a-3p/19b-3p by targeting TGF-β R II during TGF-β1-induced fibrogenesis in human cardiac fibroblasts, Sci Rep, 6, 24747, 10.1038/srep24747

Tijsen, 2014, The microRNA-15 family inhibits the TGFβ-pathway in the heart, Cardiovasc Res, 104, 61, 10.1093/cvr/cvu184

Heger, 2011, TGFβ receptor activation enhances cardiac apoptosis via SMAD activation and concomitant NO release, J Cell Physiol, 226, 2683, 10.1002/jcp.22619

Ebelt, 2013, Treatment with bone morphogenetic protein 2 limits infarct size after myocardial infarction in mice, Shock, 39, 353, 10.1097/SHK.0b013e318289728a

Zeisberg, 2003, BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury, Nat Med, 9, 964, 10.1038/nm888

Dobaczewski, 2010, Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction, Circ Res, 107, 418, 10.1161/CIRCRESAHA.109.216101

Biernacka, 2015, Smad3 signaling promotes fibrosis while preserving cardiac and aortic geometry in obese diabetic mice, Circ Heart Fail, 8, 788, 10.1161/CIRCHEARTFAILURE.114.001963

Tan, 2010, Targeted inhibition of activin receptor-like kinase 5 signaling attenuates cardiac dysfunction following myocardial infarction, Am J Physiol Heart Circ Physiol, 298, H1415, 10.1152/ajpheart.01048.2009

Engebretsen, 2014, Attenuated development of cardiac fibrosis in left ventricular pressure overload by SM16, an orally active inhibitor of ALK5, J Mol Cell Cardiol, 76, 148, 10.1016/j.yjmcc.2014.08.008

Anderton, 2011, Induction of heart valve lesions by small-molecule ALK5 inhibitors, Toxicol Pathol, 39, 916, 10.1177/0192623311416259

Wei, 2013, Smad7 inhibits angiotensin II-induced hypertensive cardiac remodelling, Cardiovasc Res, 99, 665, 10.1093/cvr/cvt151

Matsumoto-Ida, 2006, Activation of TGF-beta1-TAK1-p38 MAPK pathway in spared cardiomyocytes is involved in left ventricular remodeling after myocardial infarction in rats, Am J Physiol Heart Circ Physiol, 290, H709, 10.1152/ajpheart.00186.2005